Seeking Alpha
 

Celsion Corporation (CLSN)

- NASDAQ
  • Clinically Sound Investor | Send Message 18 Mar

    Celsion Corporation Has Significant Upside In Q2 With An Unexpected Income Source $CLSN http://seekingalpha.com/a/1sj94
    Reply
      • LaboMedic | Send Message 24 Feb

        $CLSN Cantor Maintains Buy On Celsion Following Update On ThermoDox HEAT Study http://bit.ly/17SOeiD
        Reply
          • PatrickTS | Send Message 23 Feb

            Research for 23.02: $AXN $CRMD $IBIO $CLSN $ARIA $THRX $CAPN
            Reply
              • Clinically Sound Investor | Send Message 20 Nov 2014

                Celsion's Prospects For A Significant Upside Just Got A Lot Better $CLSN http://seekingalpha.com/a/1lrul
                Reply
                  • LaboMedic | Send Message 13 Nov 2014

                    $CLSN H.C. Wainwright Reiterates Buy On Celsion Following Release Of 3Q14 Results http://bit.ly/1GT71be
                    Reply
                      • HoleInOne | Send Message 31 Oct 2014

                        Celsion Gets Some Love From Cantor Fitzgerald ...Target $7.00 $CLSN http://seekingalpha.com/p/219un
                        Reply
                          • Quoth the Raven | Send Message 30 Jul 2014

                            Celsion Showing Small Signs Of Life After Tanking 95% $CLSN http://seekingalpha.com/a/1ek37
                            Reply
                              • May Tepper | Send Message 29 Jul 2014

                                $CLSN HC Wainwright Reiterates Buy On Celsion Following The Company's Latest Announcements http://bit.ly/1tnagT7
                                Reply
                                  • Sharon di Stefano | Send Message 22 Jul 2014

                                    Celsion's EGEN Acquisition Brings Immunotherapy And RNA Therapeutics To Its Cancer Platform $CLSN http://seekingalpha.com/a/1dxo9
                                    Reply
                                      • May Tepper | Send Message 16 Jul 2014

                                        $CLSN H.C. Wainwright Reiterates Buy On Celsion Following Meeting With Management http://bit.ly/1oIU7k0
                                        Reply
                                          Visit Seeking Alpha's
                                          CLSN vs. ETF Alternatives
                                          Company Description
                                          Celsion Corpis a fully-integrated oncology drug development company. The Company is engaged in developing a portfolio of cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA-based therapies.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States